company background image
PPP logo

Phong Phu Pharmaceutical HNX:PPP Stock Report

Last Price

₫20.30k

Market Cap

₫178.6b

7D

2.5%

1Y

12.8%

Updated

17 Jun, 2025

Data

Company Financials

Phong Phu Pharmaceutical Joint Stock Company

HNX:PPP Stock Report

Market Cap: ₫178.6b

Phong Phu Pharmaceutical (PPP) Stock Overview

Engages in the production, sale, and distribution of medicines primarily in Vietnam. More details

PPP fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends3/6

PPP Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Phong Phu Pharmaceutical Joint Stock Company Competitors

Price History & Performance

Summary of share price highs, lows and changes for Phong Phu Pharmaceutical
Historical stock prices
Current Share Price₫20,300.00
52 Week High₫22,100.00
52 Week Low₫15,700.00
Beta0.035
1 Month Change3.57%
3 Month Change4.10%
1 Year Change12.78%
3 Year Change40.00%
5 Year Change20.12%
Change since IPO112.67%

Recent News & Updates

Recent updates

Shareholder Returns

PPPVN PharmaceuticalsVN Market
7D2.5%1.1%2.0%
1Y12.8%8.8%4.2%

Return vs Industry: PPP exceeded the VN Pharmaceuticals industry which returned 7.5% over the past year.

Return vs Market: PPP exceeded the VN Market which returned 2.2% over the past year.

Price Volatility

Is PPP's price volatile compared to industry and market?
PPP volatility
PPP Average Weekly Movement8.5%
Pharmaceuticals Industry Average Movement4.9%
Market Average Movement6.1%
10% most volatile stocks in VN Market8.5%
10% least volatile stocks in VN Market4.3%

Stable Share Price: PPP's share price has been volatile over the past 3 months compared to the VN market.

Volatility Over Time: PPP's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of VN stocks.

About the Company

FoundedEmployeesCEOWebsite
2000212n/aduocphongphu.vn

Phong Phu Pharmaceutical Joint Stock Company engages in the production, sale, and distribution of medicines primarily in Vietnam. The company’s medicines are derived from medicinal herbs, pharmaceutical chemicals, and health protection food, that are offered in tablets, film-coated, sugar-coated, soft capsules, granules, powder, and other forms. It offers its products for respiratory, spiritual, anti-inflammatory, anti-allergic, digest, cardiovascular, diabetes, liver function, and osteoarthritis, as well as provides vitamins and minerals.

Phong Phu Pharmaceutical Joint Stock Company Fundamentals Summary

How do Phong Phu Pharmaceutical's earnings and revenue compare to its market cap?
PPP fundamental statistics
Market cap₫178.64b
Earnings (TTM)₫17.46b
Revenue (TTM)₫141.69b
10.2x
P/E Ratio
1.3x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PPP income statement (TTM)
Revenue₫141.69b
Cost of Revenue₫92.83b
Gross Profit₫48.86b
Other Expenses₫31.40b
Earnings₫17.46b

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)1.98k
Gross Margin34.49%
Net Profit Margin12.32%
Debt/Equity Ratio0%

How did PPP perform over the long term?

See historical performance and comparison

Dividends

7.4%
Current Dividend Yield
75%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/06/17 04:57
End of Day Share Price 2025/06/13 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Phong Phu Pharmaceutical Joint Stock Company is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.